Serengen and LDC announce collaboration May 2022
Serengen’s DELs will fuel the drug discovery projects at the Lead Discovery Center in Dortmund.
Our latest publication in Nature Nat. Rev. Methods Primers, 2, 3 (2022)
Satz et al. elaborate current status of DNA-encoded chemical library (DECL) technology.
BIO-Europe Spring digital 28th-30th March 2022
Talk to our CEO Thorsten about how DELs can solve your hit identification and lead generation challenges!
